First-ever in-utero stem cell therapy for fetal spina bifida repair shows safe results

medicalxpress - A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of spina bifida. This is the first time live ste…

AI Summary: A Phase I study reports that adding stem‑cell therapy to standard fetal surgery for spina bifida is safe and may reverse fetal brain damage. Early clinical results published in a leading journal show feasibility and encouraging biological effects, setting the stage for larger trials and cautious optimism among researchers and clinicians.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Microfluidic device recovers hidden eggs, boosts IVF yield / 3 months

Pediatricians’ immune cells yield antibody cocktail protecting against RSV and hMPV / 3 months

Sanofi ousts Paul Hudson as Belén Garijo named incoming CEO / 3 months

Low-dose peanut therapy offers safe protection for allergic children / 4 months

Bacterial Traces in Brain Tumors May Influence Their Behavior / 6 months

Experimental therapy reduces seizures in children with Dravet syndrome / 2 months

FDA approves Rocket Pharma gene therapy for ultra‑rare immune disorder / 2 months